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Abstract 
One aspect of goal-directed behavior, which is known to be impaired in patients with 
schizophrenia (SZ), is balancing between exploiting a familiar choice with known reward 
value and exploring a lesser known but potentially more rewarding option. Despite its 
relevance to several symptom domains of SZ, this has received little attention in SZ 
research. In addition, while there is increasing evidence that SZ is associated with 
chronic low-grade inflammation, few studies have investigated how this relates to 
specific behaviors, such as balancing exploration and exploitation. We therefore 
assessed behaviors underlying the exploration-exploitation trade-off using a three-
armed bandit task in 45 patients with SZ and 19 healthy controls (HC). This task 
allowed us to dissociate goal-unrelated (random) from goal-related (directed) 
exploration and correlate them with psychopathological symptoms. Moreover, we 
assessed a broad range of inflammatory proteins in the blood and related them to 
bandit task behavior. We found that, compared to HC, patients with SZ showed reduced 
task performance. This impairment was due to a shift from exploitation to random 
exploration, which was associated with symptoms of disorganization. Relative to HC, 
patients with SZ showed a pro-inflammatory blood profile. Furthermore, high sensitivity 
C-reactive protein (CRP) positively correlated with random exploration, but not with 
directed exploration or exploitation. In conclusion, we show that low-grade inflammation 
in patients with SZ is associated with random exploration, which can be considered a 
behavioral marker for disorganization. CRP may constitute a marker for severity of, and 
a potential treatment target for maladaptive exploratory behaviors. 
 
Key words: Bandit task; exploration; exploitation; disorganization; inflammation; C-
reactive protein; cytokines 
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Introduction 
Schizophrenia is a complex neuropsychiatric disorder characterized by a wide range of 
symptoms [1]. Negative symptoms and disorganization are strongly associated with 
reduced social and occupational functioning and are challenging to treat [2] [3] [4] [5]. 
Therefore, understanding the shared and dissociable mechanisms underlying these 
symptoms is crucial in increasing our knowledge about the etio-pathophysiology of the 
disorder and the much needed development of novel treatments.  
Negative symptoms and disorganization have been linked to impairments of goal-
directed behaviors [6] [7]. Investigating behaviors relevant to these symptom 
dimensions in schizophrenia with objective, task-based measures that allow the 
assessment of complex, well defined behaviors with ecological validity is crucial [8] [9]. 
The exploration-exploitation trade-off concerns the decision between exploiting a 
familiar option with known reward value and exploring a lesser known option with more 
uncertain but potentially higher reward value. This trade-off may constitute a 
paradigmatic case for assessing goal-directed behaviors, which have been shown to be 
impaired in patients with schizophrenia [10] [11]. To study the exploration-exploitation 
trade-off in a controlled experimental setting, a human computerized task, where the 
participant has to repeatedly choose between different “slot-machines” (bandits) that 
gradually change their reward values has been developed [12] [13]. Accordingly, 
participants have to decide when to switch from exploitative to exploratory strategies 
when aiming to obtain the highest total reward pay-off possible [13] [14]. An optimal 
balance between exploration and exploitation results in a maximization of the obtained 
reward and fulfils the fundamental need of foraging organisms to adapt to a complex 
and changing world (for review [15]). 
Few studies have applied exploration-exploitation tasks in patients with schizophrenia 
(SZ), but no firm conclusions can be drawn so far: Strauss and colleagues found that 
patients with SZ show decreased uncertainty-driven directed exploration, which was 
associated with clinically assessed negative symptoms [16]. Another study reported that 
patients with SZ displayed increased novelty-seeking behaviors [17]. In addition, while 
several brain regions (midbrain and prefrontal areas) and neurotransmitters (dopamine, 
noradrenaline and acetylcholine) have been implicated in mediating exploration-
exploitation trade-offs [10] [15] [18] [19], the underlying etiological mechanisms remain 
to be elucidated.  
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Inflammation has been suggested to be a key mechanism for disturbances of motivation 
and goal-directed behavior [20] [21]. Pre-clinical animal models and human studies 
have shown a close interaction between the peripheral immune system and the central 
nervous system in health and the development of neuropsychiatric disorders [22] [23]. 
Indeed, several studies have reported that patients with schizophrenia display 
alterations in immune function indexed by cytokines, chemokines and acute phase 
proteins in both blood and cerebral spinal fluid (CSF), which are indicative of chronic 
low-grade inflammation (see [24] for meta-analysis).  
Recent studies have started to investigate whether these immune changes correlate 
with specific behaviors [25]. With regard to exploration and exploitation, the concept of 
sickness behavior as an adaptive behavioral response to acute infections is of high 
relevance [26] [27]. Sickness behavior can be interpreted as a short-term disturbance of 
exploratory behaviors that could have beneficial energy-saving effects by shifting 
energy resources towards the immune system to facilitate clearing infections and wound 
healing. However, in our modern world with fewer infectious challenges and better 
sanitation, chronic-low grade inflammation might be maladaptive leading to inefficient 
performance [28]. To our knowledge, no study has so far investigated the relationship of 
a pro-inflammatory state with an objective task assessment of exploration-exploitation 
behavior, despite the high relevance for several symptom domains of SZ. Overall, we 
hypothesized that patients with SZ will display reduced task outcome based on 
impairments in balancing between exploration and exploitation behaviors and that the 
underlying behavioral impairments are associated with a low-grade, pro-inflammatory 
state. 
Therefore, we first assessed negative, disorganized and cognitive symptoms in 
pharmacologically stable patients with SZ and healthy controls (HC). We then examined 
exploration vs. exploitation behaviors using a three-armed computerized bandit task and 
investigated correlations between overall task performance, directed and random 
exploration and exploitation with psychopathological measures. Next, we assessed 
group differences (SZ vs. HC) in a broad array of cytokines and chemokines in the 
blood. To investigate and visualize the complex interaction between the individual 
inflammatory parameters and their relationship with group affiliation (SZ or HC) we used 
network analysis. Lastly, we investigated the relationships between the immune-
markers that were different between groups and task-based behaviors. 
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Methods  
2.1. Participants 
45 patients meeting the DSM-V (American Psychiatric Association, 2013) criteria for SZ 
and 19 HC subjects were recruited. Patients were recruited from outpatient and 
inpatient units of the Psychiatric Hospital of the University of Zurich and affiliated 
institutions, HC were recruited from the community via advertisement. More patients 
than controls were recruited to have adequate power for the correlational analyses (see 
below). Two patients did not complete the bandit task (due to fatigue) and are therefore 
only included in the group comparison of immune markers. Diagnoses were confirmed 
by conducting the Mini-International Neuropsychiatric Interview [29]. All patients were 
clinically stable and under a stable dose of medication for at least two weeks prior to 
testing. Inpatients were at the end of their hospitalization and engaged in a multimodal 
therapy program and activities outside the hospital. The average duration of 
hospitalization for patients with schizophrenia in Swiss psychiatric hospitals is longer 
than in most other countries, so the majority of patients would have been treated as 
outpatients in other health care systems. The inclusion age was between 18-65 years. 
We excluded patients with any other than the above mentioned DSM-IV Axis I 
disorders, lorazepam medication higher than 1mg per day and acute psychotic 
symptoms. Participants with any alcohol use disorder based on lifetime criteria and 
participants with current cannabis abuse or dependency or with any other substance 
abuse were excluded. HC were excluded if any neuropsychiatric diagnosis was present 
in the structured Mini-International Neuropsychiatric Interview. In both groups, 
participants were excluded if they had a history of head-injury or any autoimmune or 
chronic inflammatory disorder or if they took any pain-medication or anti-inflammatory 
drugs at least one week prior to testing (assessed by detailed questionnaire and 
medical records where available). Furthermore, participants were not included in the 
study if they had a history of any known acute inflammation two weeks prior to testing. 
All participants gave written informed consent and the project was approved by the 
Ethics Committee of the Canton of Zurich.  
 
2.2. Assessment of Psychopathology and Cognition 
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Negative, positive and disorganized symptoms were assessed using the five factor 
model of the Positive and Negative Syndrome Scale (PANSS) [30]. Cognition was 
assessed with the Brief Neurocognitive Assessment (BNA) [31], which was shown to be 
highly correlated with the MATRICS Consensus Cognitive Battery (MCCB) [32] and has 
similarly good validity criteria [33]. With the BNA, a cognitive score is computed for each 
participant by combining results from the Letter-Number-Span Test and the Symbol 
Coding Test. Global level of functioning was assessed using the Personal and Social 
Performance Scale (PSP) [34]. 
 
2.3. Bandit Task 
For assessing exploratory versus exploitative behavior, the participants performed a 
computerized virtual slot machine (bandit) task (Fig. S1). The procedure is an adapted 
version of a recently described bandit task [14]. Briefly, participants were shown three 
virtual slot machines depicted by 3 blue boxes on a screen between which they had to 
choose repeatedly by pressing the arrow keys on the keyboard. After each choice, the 
points they won, ranging from 1-100, were displayed. Participants were instructed to 
collect as many points as possible to maximize their gain. In foraging situations, like in 
this bandit task, decision makers need to balance exploitation with exploration. They 
were informed that the points paid out by the slot machines oscillated randomly and 
independently over trials, so they would have to choose at any given point between 
exploiting the currently used bandit and exploring the other two options to maximize 
gain. Unlike standard slots, the mean payoffs changed randomly and independently 
from trial to trial, with subjects finding information about the current worth of a slot only 
through sampling it [13]. Three brief written questions and a short practice trial to 
confirm the comprehension of the task took place before the actual task began. The 
payouts for each bandit were generated with a decaying Gaussian random walk, 
resulting in points paid off varying noisily around three different means. Reward of the 
selected option was displayed on the computer screen after each choice. If participants 
took too much time (5 seconds) deciding between the slot machines, a window popped 
up asking them to choose a machine. Participants completed 200 trials. At the end, five 
trials were randomly selected and the participants received the mean of the 
corresponding gains. To test whether participants performed better than chance, we 
simulated random choosers (equal chance to select each bandit) 1000 times for each 
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participant’s reward structure. The average total reward earned by the random choosers 
was 51.90 points. We tested whether control participants and participants with SZ 
performed better or worse than the average of random choosers. To avoid any 
unnecessary assumptions about the actual implementation of psychological functions, 
we performed model-free analyses. We defined the best, second-best and worst options 
as the options with the highest, second highest and lowest expected value in the current 
trial based on the objective reward structure of the task. Continuously selecting the best 
option was defined as exploitation. There was a significant correlation between the 
average length of consecutively selecting the best option and points earned in the task 
(r(s) = 0.53, p < 0.001), further validating our measure of exploitation. Since the points 
paid out by the slot machines oscillated randomly and independently over trials, 
exploitative behavior will result in nonoptimal condition where people have insufficient 
information about the current reward structure. Ideally, decision makers should balance 
exploitation with exploration. To further disentangle different forms of exploratory 
behaviors, we distinguished directed from random exploration based on the uncertainty 
associated with each option [35] [36] [37]. The less often a given bandit has been 
chosen, the less information the decision maker has about the bandit. Accordingly, 
directed exploration corresponds to choosing the option that provides most information 
for future decisions, and can be viewed as goal-directed uncertainty reduction. In 
contrast, random exploration can be interpreted as a noisy behavior, which provides 
little or no extra information. In our task, directed exploration corresponds to a shift to 
the least selected option while shifts to more often selected options correspond to 
random exploration. A less-well established alternative definition of directed and random 
exploration is based on the value of each option, with value-based directed exploration 
defined as switching from the best option to the second best option. In the supplemental 
material, we show that the main findings of the present study remained qualitatively the 
same using this alternative definition (Fig. S2). 
 
2.4. Blood samples and processing 
Blood was drawn between 8-10 am on the day of testing. Study participants were 
instructed to fast for at least 8 hours prior to the blood draw and this was verified by a 
questionnaire on the day of testing. To obtain plasma for Olink panel, blood was drawn 
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into ethylenediaminetetraacetic acid (EDTA) tubes (Sarstedt, Switzerland), centrifuged 
for 15min at 1500g and plasma was frozen at -80°C. High sensitivity C-reactive protein 
(CRP) was measured in serum: blood was collected into a silica and gel containing tube 
(BD Vacutainer).  
 
2.5. CRP 
 CRP was measured in participant serum samples by immunoturbidimetry on Abbott 
Architect c16000 or c8000, at Unilabs Medical Analytics in Duebendorf / Zurich, 
Switzerland. 
 
2.6. Cytokines and chemokines 
Proteins were measured using the Olink® Inflammation panel (Olink Proteomics AB, 
Uppsala, Sweden) according to the manufacturer's instructions. The Proximity 
Extension Assay (PEA) technology used for the Olink protocol is described in detail in 
[38]. In brief, pairs of oligonucleotide-labeled antibody probes bind to their targeted 
protein, and if the two probes are brought in close proximity the oligonucleotides will 
hybridize in a pair-wise manner. The addition of a DNA polymerase leads to a proximity-
dependent DNA polymerization event, generating a unique PCR target sequence. The 
resulting DNA sequence is subsequently detected and quantified using a microfluidic 
real-time PCR instrument (Biomark HD, Fluidigm). Data is then quality-controlled and 
normalized using an internal extension control and an inter-plate control, to adjust for 
intra- and inter-run variation. The final assay readout is presented in Normalized Protein 
expression (NPX) values, which is an arbitrary unit on a log2-scale where a high value 
corresponds to a higher protein expression. Detection limits are available on the 
manufacturer's website (www.olink.com). In total, 91 proteins were measured with an 
intra- and inter-assay coefficient of variance of < 10%. We excluded 19 proteins due to 
>80% values below the limit of detection (LOD). Values below the LOD were replaced 
with the LOD for the specific assay. 5 participants (2 HC, 3 SZ) were excluded because 
their samples failed quality control.  
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2.7. Data analysis 
All variables were tested for normal distribution using the Kolmogorov-Smirnov test. If 
variables were normally distributed, potential group differences were examined using 
two-sided Students t-tests. To investigate correlations between inflammatory 
parameters and task variables / psychopathology, Pearson correlation coefficients r(p) 
were calculated. If data were not normally distributed, we instead used Mann Whitney U 
tests and Spearman correlation coefficients r(s). Heatmaps of inflammatory markers are 
based on standardized scores that were calculated as: (value of SZ (individual sample 
value) – mean of HCs)/ standard deviation of HCs). The level of significance was set at 
p < 0.05. To investigate group differences in inflammatory markers between HC and 
patients with SZ, we used an exploratory approach using uncorrected test statistics and 
network analysis (see below). Correlations between immune-markers and task behavior 
was controlled for multiple comparisons using the procedure proposed by Benjamini 
and Hochberg [39]. General linear models were used to test for the effects of covariates 
on group differences and partial correlations were calculated when controlling for 
covariates in the correlational analyses. Effect size was assessed by calculating 
Cohen’s d. Statistical analyses were computed with SPSS version 25 (IBM Corp., SPSS 
Inc., Chicago IL, USA), Stata version 14.2 (StataCorp. 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp LP), Matlab version R2018a (The 
MathWorks, Inc., Natick, Massachusetts, United States), R (Version 3.4.0, [40] and 
GraphPad Prism software (GraphPad Software Inc.). Heat maps were created using the 
online tool Morpheus (https://software.broadinstitute.org/morpheus). 
 
2.8. Network analysis 
Network analyses followed a four-step procedure: i) Data preparation: All variables for 
which the t-test for differences in blood levels of investigated inflammation markers 
between patients with SZ and HC had a p-value < 0.05 before correction for multiple 
testing were included in the network. ii) Network estimation and visualization: The 
estimated network is a Gaussian Graphical Model, in which the nodes represent the 
included variables. Edges between these variables can be interpreted as undirected, 
weighted partial correlations. Partial correlations can be thought of as the "unique" 
correlation between two nodes after controlling for the correlation with all other nodes 
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[41]. We then visualized the network, with the thickness of an edge corresponding to its 
weight and with the color indicating a positive (red) or negative (blue) partial correlation 
between two nodes. Placement of the nodes for the visualization was based on the 
Fruchterman-Reingold-algorithm [42]. iii) Network characterization: We estimated 
centrality indices, which are a relative marker for the influence of a node on the network 
as a whole (for detail see: [43]). iv) Network accuracy and stability: Using current state 
of the art procedures, we calculated 95% confidence intervals for the edge weights and 
difference test for centrality and edge weights. All network analyses were carried out in 
R (Version 3.6.1, [40]) using the package bootnet [41]. Networks were visualized using 
qgraph [44]. Detailed information about network analysis are provided in the SI. 
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Results 
3.1. Sociodemographic data  
Sociodemographic and clinical data of the sample are summarized in Table 1. Our SZ 
sample showed a wide range of negative and disorganized symptoms, and few positive 
symptoms. Patients with SZ completed fewer years of formal education (p = 0.003) and 
had a higher Body mass index (BMI) (p = 0.009) than HC. The SZ group displayed a 
significantly lower score in PSP as a measure of global level of functioning (p < 0.001). 
Patients with SZ also displayed a lower cognitive score (p < 0.001).  
 
Insert Table 1 here. 
 
3.2. Patients with SZ display impaired performance in the exploration-exploitation bandit 
task  
First, the total reward earned from the bandit task was calculated for each group. 
Patients with schizophrenia obtained significantly fewer points than HC (HC: 62.9 ± 5.0; 
SZ: 59.1 ± 4.7), t = 2.89 p = 0.005, d = 0.78) (Fig. 1A). Both HC and patients with 
schizophrenia earned significantly more than the simulated random chooser (random 
choosers: 51.9, HC: p < 0.0001, SZ: p < 0.0001). Thus, even though patients with SZ 
earned less than HC, individuals with SZ clearly performed better than chance.  
Insert Figure 1 here. 
In a next step, we aimed to investigate potential reasons for why patients with SZ 
earned less reward than HC. To do so, we analyzed exploration and exploitation 
behaviors. We found that exploitation, defined as the continuous selection of the best 
bandit option, was reduced in patients with SZ (HC: 5.71 ± 2.3; SZ: 4.65 ± 1.5), t = 2.14, 
p = 0.036, d = 0.55) (Fig. 1B). In contrast, there were no significant differences between 
groups in the length of consecutively selecting other options (p’s > 0.7). We then tested 
whether there were group differences in exploratory behaviors. SZ patients showed 
more random exploration (HC = 23.32 ± 13.3, SZ = 35.63 ± 23.1; U = 275.5, p= 0.042, d 
= 0.65) (Fig. 1C) but similar levels of directed exploration (HC = 13.6 ± 6.7, SZ = 19.6 ± 
13.7; U = 302, p = 0.104) (Fig. 1D). Furthermore, there was a significant negative 
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correlation between random exploration and points earned in the task (r(p) = -0.34, p = 
0.025) in patients with SZ. 
Next, we performed correlational analyses between the task parameters and three 
psychopathological domains relevant to schizophrenia: negative symptoms, symptoms 
of disorganization and cognitive symptoms. Interestingly, symptoms of disorganization, 
assessed by the PANSS disorganized factor, correlated positively with random 
exploration (r(s) = 0.31, p = 0.045) and negatively with exploitation (r(s) = -0.36, p = 
0.018), the two task parameters that contributed to the decreased overall task 
performance in SZ patients compared to HC, but not with directed exploration (r(s) = 
0.27, p = 0.078). While we observed a significant negative correlation between the 
PANSS disorganized factor and composite cognitive score (r(s) = -0.33, p = 0.029), task 
parameters did not correlate with cognitive or negative symptoms (Table S1). Since 
antipsychotic medications are known to have an influence on various behaviors and 
cognition, we correlated chlorpromazine equivalents with task parameters, but did not 
observe a significant correlation (Table S1). 
Together, our data show that patients with SZ display impaired task performance since 
they earned fewer points in the bandit task. Analyzing the underlying behaviors revealed 
that this deficit is due to an increased random exploration and decreased exploitation, 
which both correlated with the PANSS disorganized factor.   
 
3.3. Patients with SZ show a pro-inflammatory phenotype  
To investigate group differences in blood immune profiles between SZ and HC, we used 
two different exploratory strategies. First, we investigated group differences of individual 
immune parameters between HC and patients with SZ. Several immune markers 
differed between groups, indicative of a pro-inflammatory phenotype in patients with SZ 
compared to HC (Fig. 2A): C-reactive protein (CRP) (U = 243.5, p = 0.007, d = 0.96), 
Interleukin (IL)-6 (t = 2.31, p = 0.025, d = 0.74), Tumor Necrosis Factor (TNF)-related 
apoptosis-inducing ligand (TRAIL) (t = 4.16, p < 0.001, d = 1.05), TNF-related 
activation-induced cytokine (TRANCE) (t = 2.09, p = 0.041, d = 0.59), Fibroblast Growth 
Factor 21 (FGF-21) (t = 2.19, p = 0.033, d = 0.61), Chemokine Ligand (CCL) 2 (t = 2.05, 
p = 0.045, d = 0.61), CCL7 (t = 2.23, p = 0.030, d = 0.71), CCL11 (t = 2.75, p = 0.008, d 
= 0.83) and CCL20 (U = 158.5, p < 0.001, d = 1.02) were increased in the SZ group, 
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while Stem Cell Factor (SCF) (t = 2.13, p = 0.038, d = 0.62), CXCL11 (U = 223, p = 
0.026, d = 0.56) and CCL28 (U = 183.5, p = 0.003, d = 0.48) were decreased. 
CRP (p = 0.022), TRAIL (p = 0.001), CCL20 (p = 0.003), CCL7 (p = 0.027) and CCL11 
(p = 0.010) remained significantly different after controlling for age, sex and BMI. 
 
Insert Figure 2 here. 
 
We then performed network analysis of the inflammatory markers that were significantly 
different between the two groups. Given that cytokines and other pro-inflammatory 
markers are known to influence each other reciprocally, network analysis can reveal 
distinct associations between group affiliation and the included proteins. Controlling for 
the associations with all other variables in the network, we found group affiliation to be 
uniquely correlated with several inflammatory markers, most strongly with CCL20, 
TRAIL and CRP (Fig. 2B, Fig. S3 – S7).  
Together, several pro-inflammatory cytokines and chemokines were elevated in patients 
with SZ compared to HC, indicative of a pro-inflammatory state. Across all the analyses, 
CRP, CCL20 and TRAIL were most strongly associated with group. 
 
3.4. Random but not directed exploration is associated with increased CRP 
Finally, we correlated bandit task behaviors with TRAIL, CCL20 and CRP, the immune 
parameters that were most strongly associated with group across the analyses. To 
control for multiple comparisons, significance level was set at p < 0.017 (0.05 / 3 
parameters).  
We found a significant positive correlation of CRP with random exploration (r(s) = 0.40, 
p = 0.008) (Fig. 3A), but not exploitation (r(s) = -0.27, p = 0.081) (Fig. 3B), or directed 
exploration (r(s) = 0.17, p = 0.284) (Fig. 3C). The correlation between random 
exploration and CRP remained significant after controlling for age, BMI, sex, cognition 
and chlorpromazine equivalents (r = 0.33, p = 0.046). There were no correlations of 
CCL20 or TRAIL with task parameters (Table S3).  
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Insert Figure 3 here. 
Discussion 
In the present study, we investigated the link between shifted balancing of exploration 
versus exploitation using an objective task-based measure, and inflammatory 
parameters in patients with SZ. Compared to HC, patients with SZ showed reduced 
performance in the bandit task. Furthermore, we demonstrated that reduced task 
performance was associated with increased random exploration in SZ. Random 
exploration correlated with the acute-phase protein CRP. 
To our knowledge, the specific increase in random exploration associated with reduced 
overall performance has not been previously reported for patients with SZ. However, in 
the study of Martinelli and colleagues, patients with SZ showed increased novelty 
seeking on a different version of the three-armed bandit task [17]. Although the task and 
the analysis are not directly comparable, their findings are consistent with ours as 
novelty seeking and random exploration tap into similar functions. In addition, several 
studies using simpler tasks have shown that patients with SZ display impaired ability to 
keep their best decisions and instead more often show “win-shift” behaviors, which is in 
line with our finding of reduced exploitation [45] [46]. In contrast to findings from our 
study, Strauss and colleagues showed, using a “temporal utility integration task” that, 
compared to HC, patients with SZ have decreased uncertainty-driven directed 
exploration, an effect that was most pronounced in patients with SZ with high levels of 
negative symptoms [16]. Further, directed exploration was negatively associated with 
anhedonia in SZ [16]. Although the use of different tasks makes direct comparisons 
difficult, it is interesting that in the present study patients with SZ did not show 
differences in directed exploration or correlations of negative symptoms with task 
parameters.  
 
Instead, we observed a positive correlation between symptoms of disorganization and 
random exploration. Compared to other symptom domains, symptoms of 
disorganization have been the least studied, but are closely linked to functional 
outcomes [47] [2]. Specifically, they have been associated with lack of insight [48], lower 
quality of life [49] and impaired long-term functioning [50]. In addition, several studies 
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have shown that symptoms of disorganization are related to symptoms of cognition [51] 
[47]. In line with these findings, we show a negative correlation between PANSS 
disorganized factor and cognitive score. However, the increased random exploration 
cannot be solely explained by cognition because we did not find a correlation between 
cognitive score and task behaviors. Taken together, our data suggest that exploratory 
behaviors assessed by the bandit task are less relevant to negative symptoms but are 
more related to symptoms of disorganization, i.e. impairment of integrating complex 
inputs about a changing environment into an organized, efficient process.  
 
The neural mechanisms underlying exploration-exploitation trade-offs and random 
exploration in particular have not been fully elucidated yet. Several neurotransmitters, 
including dopamine, acetylcholine and norepinephrine have been suggested to 
modulate exploration-exploitation trade-offs [10]. While the neuromodulator dopamine 
has been consistently implicated in balancing exploration with exploitation [35] [52] [53], 
the underlying etiological causes of this dopamine dysregulation are not well 
understood. There is a growing body of evidence indicating that pro-inflammatory 
cytokines can directly influence dopamine neurotransmission [20]. We therefore 
investigated if a pro-inflammatory state is associated with the observed task-
performance deficits and in extension the hypothesized hypodopaminergic state. In line 
with previous research [25], patients with SZ showed a pro-inflammatory state. Across 
all the analyses investigating group differences of inflammatory parameters, CCL20, 
TRAIL and CRP were most strongly associated with SZ group affiliation. In addition, 
CRP was positively correlated with random exploration, the task-behavior that 
contributed to decreased overall task performance.  
 
The acute-phase protein CRP has numerous functions in the body’s immune response, 
including the induction of cytokine production and activation of the complement pathway 
[54] [55]. While CRP itself does not cross the blood brain barrier (BBB), peripheral CRP 
was shown to directly increase the permeability of BBB by reducing tight junction 
proteins [56]. This increased BBB permeability could facilitate the access of potentially 
neurotoxic substances such as pro-inflammatory cytokines, peripheral leukocytes or 
autoantibodies to the brain [25] [57]. Taken together, the current data suggest that 
patients with SZ show increased pro-inflammatory markers compared to HC and that 
CRP is associated with increased inefficient, random exploration. 
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There are several limitations that should be considered when interpreting the results of 
the current study: First, patients were medicated, and although a recent meta-analysis 
has not found an effect of antipsychotics on CRP [25], a confounding effect of 
antipsychotics on both behavior and metabolism cannot be excluded. Moreover, to 
causally test the hypothesis that peripheral inflammatory mediators can indeed 
influence neurotransmitter levels leading to behavioral changes, future studies directly 
measuring dopamine and pharmacologically blocking dopamine receptors in 
combination with experimentally induced immune challenges in HC, patients with SZ, 
and pre-clinical models are needed.  
 
Taken together, the present study suggests that patients with SZ are more likely to 
randomly explore than HC and that this behavior is associated with symptoms of 
disorganization. Importantly, this inefficient form of exploratory behavior is associated 
with a pro-inflammatory state. Further studies are needed to elucidate the underlying 
mechanism of how CRP leads to the neurobiological changes resulting in the observed 
behavioral alterations. Nevertheless, our data suggest that CRP could be a marker for 
the severity and treatment course of and potentially a therapeutic target for maladaptive 
exploratory behaviors in schizophrenia and potentially other neuropsychiatric disorders.  
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Figure and Table Legends 
Figure 1. A) Patients with schizophrenia (SZ) earned fewer points in a three armed 
bandit task than healthy controls (HC). Compared to HC, patients with SZ B) displayed 
reduced exploitation of the best option, and showed C) more random exploration, but D) 
little differences in directed exploration. * p < 0.05, ** p < 0.01. 
 
Fig. 2. A) Heat maps of standardized z-scores of inflammatory markers. Red indicates 
increased expression and blue decreased expression. B) Network analysis. The 
thickness of an edge corresponds to its weight. Lines indicate positive (red) or negative 
(blue) partial correlation between two nodes. * p < 0.05, ** p < 0.01, *** p < 0.001. For a 
list of abbreviations see Table S2. 
 
Fig. 3. Within patients with schizophrenia, correlation of high sensitivity C-reactive 
protein (CRP) with A) random exploration was significant, in contrast to correlation with 
B) exploitation or C) directed exploration. 
 
Table 1. Data are presented as means (standard deviations). P values lower than 0.05 
are indicated in bold. 1Compulsory education in Switzerland is 9 years. 2Negative factor: 
N1, N2, N3, N4, N6, G7. 3Positive factor: P1, P3, P5, G9. 4Disorganized factor; P2, G5, 
N11. 5Cognition data have been z-transformed based on the data of the healthy control 
group for each test separately. The cognitive score was computed as the mean of the z-
transformed test scores on subject level. Abbreviations: BMI: body mass index; HC: 
Healthy controls; PANSS: Positive and Negative Syndrome Scale; PSP: Personal and 
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Table 1 HC (n=19) SZ (n=45) Test statistics  
   (t/χ2/U) p 
Age (years)  32.53 (9.45) 34.00 (10.47) t=-0.53 0.60 
Sex (male/female)  9/10 31/14 χ2=2.64 0.16 
Formal education (years)1 14.39 (2.23) 12.26 (3.88) U=227 0.003 
Number of hospitalizations  - 5.42 (5.44) - - 
Number of psychotic episodes - 5.31 (5.14) - - 
Chlorpromazine equivalents (mg/day) - 514.67 (444.82) - - 
Benzodiazepines (mg) - 0.06 (0.22) - - 
Body mass index 23.40 (4.32) 26.40 (4.66) U=250 0.009 
         
Psychopathology         
PANSS negative factor2 - 15.49 (6.82) - - 
PANSS positive factor3 - 5.96 (2.70) - - 
PANSS disorganized factor4 - 5.87 (2.48) - - 
     
Cognition        
Letter Number Span Test 20.16 (2.06) 18.84 (1.93) U=254.5 0.02 
Symbol Coding Test 81.94 (18.75) 59.43 (13.28) t=4.62 <0.001 
Cognitive score5 0 (0.68) -0.84 (0.70) t=4.32 <0.001 
     
Functioning     
PSP (total) 97.05 (4.70) 51.78 (14.42) U=2 <0.001 
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